Specialty Diagnostics — Goodwill
Business Segments · GoodwillThermo Fisher Scientific Specialty Diagnostics — Goodwill increased by 6.1% to $5.08B in Q4 2025 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2013
Last reportedQ4 2025
Rolls up toGoodwill
How to read this metric
An increase suggests recent M&A activity, while a decrease may indicate impairment charges due to underperforming acquisitions.
Detailed definition
Represents the intangible asset value recorded when the Specialty Diagnostics segment acquires another business for a pr...
Peer comparison
Common across life science and diagnostic peers like Danaher or Abbott, reflecting historical consolidation strategies.
Metric ID:
tmo_segment_specialty_diagnostics_goodwillHistorical Data
3 periods
| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $4.92B | $4.78B | $5.08B |
| QoQ Change | — | -2.8% | +6.1% |
| YoY Change | — | -2.8% | +6.1% |
Range$4.78B – $5.08B
Avg YoY Growth+1.6%
Median YoY Growth+1.6%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's specialty diagnostics — goodwill?
- Thermo Fisher Scientific (TMO) reported specialty diagnostics — goodwill of $5.08B in Q4 2025.
- What does specialty diagnostics — goodwill mean?
- The premium paid for acquired businesses within the Specialty Diagnostics segment that exceeds the value of their tangible assets.